http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2335177-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd39e399d54bfa3230f80bb1d12c9bb4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 |
| filingDate | 2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83a29b3d0af377610562844b08d10c4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28c50b8f470d1dfea013653e27972d1e |
| publicationDate | 2010-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2335177-A1 |
| titleOfInvention | PROPER IMMUNOTHERAPEUTIC AGENT FOR THE PRIMARY PROFILAXIS OF TUBERCULOSIS. |
| abstract | Appropriate immunotherapeutic agent fornprimary tuberculosis prophylaxis.n n n The present invention relates to the use of an immunotherapeutic agent comprising cell wall fragments of a virulent strain of Mycobacterium tuberculosis for the preparation of a medicament suitable for the primary prophylaxis of tuberculosis. The immunotherapeutic agent is capable of inducing a more effective than conventional BCG vaccine protective response and reduces the number of viable bacilli in the lungs and spleen of newly infected individuals M. tuberculosis. |
| priorityDate | 2008-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.